Effect of omeprazole on antral duodenogastric reflux in Barrett oesophagus

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 8, 2000, Pages 796-801

  Manifold, D K ^a   Marshall, R E K ^a   Anggiansah, A ^a   Owen, W J ^a  

^a NONE   (United Kingdom)

Author keywords

Ambulatory bilirubin monitoring; Barrett oesophagus; Bilitec; Duodenogastric reflux; Omeprazole; pH monitoring; Proton pump inhibitor

Indexed keywords

BILIRUBIN; OMEPRAZOLE; PROTON PUMP INHIBITOR;

AMBULATORY MONITORING; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENOGASTRIC REFLUX; ESOPHAGUS DISEASE; ESOPHAGUS MANOMETRY; HUMAN; PRIORITY JOURNAL; STOMACH PH; TREATMENT OUTCOME;

EID: 0033821499     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750023147     Document Type: Article

References (44)

1. The Barrett Committee meeting of the International Society for Diseases of the Oesophagus
2. Working party report to the World Congresses of Gastroenterology, Sydney 1990: Barrett's oesophagus
3. Gastroesophageal reflux disease in patients with columnar-lined esophagus
4. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease
5. Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat oesophagus
6. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
7. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux
8. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade
9. Esophageal mucosal resistance. A factor in esophagitis
10. Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus
11. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus
12. Intra-gastric variation of duodenogastric reflux
13. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique
14. A new fibreoptic sensor for ambulatory enterogastric reflux detection
15. The origin of nocturnal intragastric pH rises in healthy subjects
16. Duodenogastric reflux in patients with Barrett's esophagus
17. Quantification of duodenogastric reflux in Barrett's oesophagus
18. Duodenogastric reflux of bile in health: The normal range
19. Effects of acute psychologic stress on small-intestinal motility in health and the irritable bowel syndrome
20. Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility
21. Validation studies of Bilitec 2000: An ambulatory duodenogastric reflux monitoring system
22. Intra-subject variability of duodenogastric reflux
23. Measuring duodenogastro-oesophageal reflux (DGOR)
24. Assessment of non-acid esophageal reflux: Comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring
25. Duodenogastric reflux: An update
26. Mechanism of action of omeprazole
27. Omeprazole: Mode of action and effect on acid secretion in animals
28. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis
29. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum pepsinogen I levels
30. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily
31. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery
32. Effect of omeprazole - Gastric proton pump inhibitor - On pentagastrin stimulated acid secretion in man
33. A double-blind placebo-controlled study on the effects of omeprazole on gut hormone secretion and gastric emptying rate
34. The effects of omeprazole on inter-digestive motility and early post-prandial levels of gastrin and secretin
35. Omeprazole causes delay in gastric emptying of meals
36. Acid suppression by omeprazole inhibits gastric emptying in normal subjects
37. Short report: A double-blind placebo-controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects
38. The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease
39. A double-blind placebo controlled trial on characteristics of the migrating motor complex in healthy volunteers
40. Effect of gastrin II on gastric emptying and secretion during a test meal
41. Continuous monitoring of the effect of pentagastrin on gastric emptying of solid food in man
42. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers
43. Fibre-optic technique for 24 hour bile reflux monitoring: Standards and normal values for gastric monitoring
44. Changes in overnight fasting intragastric pH show poor correlation with duodenogastric bile reflux in normal subjects